Koers PHILIPS KON JUN9 Euronext Amsterdam
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 18,8 mld. 20,1 mld. 0 | Omzet 2025 * | 19,73 mld. 21,1 mld. 0 | Marktkapitalisatie | 17,9 mld. 19,14 mld. 0 |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 702 mln. 751 mln. - | Nettowinst (verlies) 2025 * | 1,12 mld. 1,19 mld. - | EV/omzet 2024 * | 1,23 x |
Nettoschuld 2024 * | 5,27 mld. 5,63 mld. 0 | Nettoschuld 2025 * | 4,3 mld. 4,6 mld. 0 | EV/omzet 2025 * | 1,12 x |
K/w-verhouding 2024 * |
27,9
x | K/w-verhouding 2025 * |
17,4
x | Werknemers | - |
Dividendrendement 2024 * |
4,48% | Dividendrendement 2025 * |
4,66% | Vrij verhandelbaar | 99,16% |
Recentste transcriptie over PHILIPS KON JUN9
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 01-01-10 |
Director of Finance/CFO | 62 | 01-01-87 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 01-01-15 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 01-01-22 |
Director/Board Member | 68 | 01-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,07% | 219 mld. | |
+6,59% | 183 mld. | |
+11,26% | 133 mld. | |
+26,57% | 108 mld. | |
+0,65% | 63,06 mld. | |
+13,35% | 52,02 mld. | |
-0,62% | 48,2 mld. | |
-0,93% | 40,37 mld. | |
+11,54% | 39,35 mld. |